Top 5 pharma doubles its Medical Affairs impact and saves 120 hours per MSL per year with Share of Scientific Voice™
CASE STUDY: Top 5 pharma DOUBLES its Medical Affairs impact and saves 120 hours per MSL per year.
Transforming KOL engagement and Medical Affairs impact with world-leading data and Share of Scientific Voice™
Request a demoAs of August 2022, Pharmaspectra became an IQVIA business. This further strengthened and widened the capabilities available to our clients as we joined together our world-leading data and solutions.
Since our full integration into IQVIA is now complete, it will soon be time to retire the Pharmaspectra brand.
Early in 2024, content of the current Pharmaspectra website will transition to IQVIA.com to provide an optimized experience and access to the breadth of IQVIA’s solutions.
For now, you can still browse content on the Pharmaspectra website or log in to the platform.
Alternatively, click here to access the relevant page on IQVIA.com, where you can also log in to the Pharmaspectra platform.
Whatever the geographical region or therapeutic area, we have the largest collection of meetings abstracts, from international and national congress to local meetings and hospital grand rounds.
Superior data and analytics power a set of game-changing solutions that maximize your resources and impact
We work with 18 of the world's top 25 pharmaceutical companies. Here's what they say about us...
Pharmaspectra’s data set stands out, but the greatest value comes from their actionable KOL insights and measurement which have made a difference for even my most experienced teams.Holly Schachner Former Chief Medical Officer, Allergan Specialty Medicine
The breadth and depth of the data that Pharmaspectra provides, allows evidence-based decision-making across all medical functionsCharles Hugh-Jones CEO Volastra Therapeutics
In pediatrics and rare diseases, there are few very relevant experts. Publications inform on experts from a few years ago, but meeting abstracts can help identifications a few months ahead. In this way, Pharmaspectra’s data provides unique support.Frank Tennigkeit Pediatric & Rare Disease Development Lead, UCB
I am grateful to the Pharmaspectra team for their impressive overview of current and relevant information. Thanks to their proactive conference support, I was able to identify some interesting contributions at diabetes congresses by German KOLs who were not previously known to me.Dr. Mussa Arvani Head of Medical Science Liaison, Sanofi
CASE STUDY: Top 5 pharma DOUBLES its Medical Affairs impact and saves 120 hours per MSL per year.
We deliver global data and analytics with tools that are comprehensive, credible and compliant
Request a demo